Longitudinal Assessment of Blood-Based Inflammatory, Neuromuscular, and Neurovascular Biomarker Profiles in Intensive Care Unit-Acquired Weakness: A Prospective Single-Center Cohort Study

Overview

Journal Neurocrit Care

Specialty Critical Care

Date 2024 Jul 9

PMID 38982001

Authors

Felix Klawitter

Friederike Laukien

Dagmar-C Fischer

Anja Rahn

Katrin Porath

Lena Danckert

Rika Bajorat

Uwe Walter

Robert Patejdl

Johannes Ehler

Affiliations

Soon will be listed here.

Abstract

Background: The diagnosis of intensive care unit (ICU)-acquired weakness (ICUAW) and critical illness neuromyopathy (CINM) is frequently hampered in the clinical routine. We evaluated a novel panel of blood-based inflammatory, neuromuscular, and neurovascular biomarkers as an alternative diagnostic approach for ICUAW and CINM.

Methods: Patients admitted to the ICU with a Sequential Organ Failure Assessment score of ≥ 8 on 3 consecutive days within the first 5 days as well as healthy controls were enrolled. The Medical Research Council Sum Score (MRCSS) was calculated, and motor and sensory electroneurography (ENG) for assessment of peripheral nerve function were performed at days 3 and 10. ICUAW was defined by an MRCSS < 48 and CINM by pathological ENG alterations, both at day 10. Blood samples were taken at days 3, 10, and 17 for quantitative analysis of 18 different biomarkers (white blood cell count, C-reactive protein, procalcitonin, C-terminal agrin filament, fatty-acid-binding protein 3, growth and differentiation factor 15, syndecan 1, troponin I, interferon-γ, tumor necrosis factor-α, interleukin-1α [IL-1α], IL-1β, IL-4, IL-6, IL-8, IL-10, IL-13, and monocyte chemoattractant protein 1). Results of the biomarker analysis were categorized according to the ICUAW and CINM status. Clinical outcome was assessed after 3 months.

Results: Between October 2016 and December 2018, 38 critically ill patients, grouped into ICUAW (18 with and 20 without) and CINM (18 with and 17 without), as well as ten healthy volunteers were included. Biomarkers were significantly elevated in critically ill patients compared to healthy controls and correlated with disease severity and 3-month outcome parameters. However, none of the biomarkers enabled discrimination of patients with and without neuromuscular impairment, irrespective of applied classification.

Conclusions: Blood-based biomarkers are generally elevated in ICU patients but do not identify patients with ICUAW or CINM.

Trial Registration: ClinicalTrials.gov identifier: NCT02706314.

References

Kleyweg R, van der Meche F, Schmitz P . Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991; 14(11):1103-9. DOI: 10.1002/mus.880141111. View

Klawitter F, Oppitz M, Goettel N, Berger M, Hodgson C, Weber-Carstens S . A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit-Acquired Weakness. Medicina (Kaunas). 2022; 58(8). PMC: 9416039. DOI: 10.3390/medicina58081068. View

Xie Y, Liu S, Zheng H, Cao L, Liu K, Li X . Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study. Biomed Res Int. 2020; 2020:3630568. PMC: 7036092. DOI: 10.1155/2020/3630568. View

Ruhnau J, Muller J, Nowak S, Strack S, Sperlich D, Pohl A . Serum Biomarkers of a Pro-Neuroinflammatory State May Define the Pre-Operative Risk for Postoperative Delirium in Spine Surgery. Int J Mol Sci. 2023; 24(12). PMC: 10298968. DOI: 10.3390/ijms241210335. View

Saller T, Petzold A, Zetterberg H, Kuhle J, Chappell D, von Dossow V . A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163(3):241-246. DOI: 10.5507/bp.2019.043. View

Vanhorebeek I, Latronico N, Van den Berghe G . ICU-acquired weakness. Intensive Care Med. 2020; 46(4):637-653. PMC: 7224132. DOI: 10.1007/s00134-020-05944-4. View

Zhang L, Zhou H, Peng Q, Jiang W, Qiao W, Wang G . Fatty acid binding protein 3 is associated with skeletal muscle strength in polymyositis and dermatomyositis. Int J Rheum Dis. 2016; 20(2):252-260. DOI: 10.1111/1756-185X.12838. View

Vanpee G, Hermans G, Segers J, Gosselink R . Assessment of limb muscle strength in critically ill patients: a systematic review. Crit Care Med. 2013; 42(3):701-11. DOI: 10.1097/CCM.0000000000000030. View

de Jonghe B, Bastuji-Garin S, Durand M, Malissin I, Rodrigues P, Cerf C . Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007; 35(9):2007-15. DOI: 10.1097/01.ccm.0000281450.01881.d8. View

10.

Wu Y, Zhang Z, Jiang B, Wang G, Wei H, Li B . Current practice and barriers to ICU-acquired weakness assessment: a cross-sectional survey. Physiotherapy. 2021; 112:135-142. DOI: 10.1016/j.physio.2021.01.002. View

11.

De Larichaudy J, Zufferli A, Serra F, Isidori A, Naro F, Dessalle K . TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle. 2012; 2(1):2. PMC: 3344678. DOI: 10.1186/2044-5040-2-2. View

12.

Llovera M, Carbo N, Lopez-Soriano J, Busquets S, Alvarez B, Agell N . Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett. 1999; 133(1):83-7. DOI: 10.1016/s0304-3835(98)00216-x. View

13.

Wondergem R, Graves B, Li C, Williams D . Lipopolysaccharide prolongs action potential duration in HL-1 mouse cardiomyocytes. Am J Physiol Cell Physiol. 2012; 303(8):C825-33. PMC: 3469715. DOI: 10.1152/ajpcell.00173.2012. View

14.

Klawitter F, Schaller S, Sohle M, Reuter D, Ehler J . [Intensive Care Unit-Acquired Weakness : A nationwide survey on diagnostics, monitoring and treatment strategies on German intensive care units]. Anaesthesiologie. 2022; 71(8):618-625. PMC: 9352631. DOI: 10.1007/s00101-022-01089-9. View

15.

Turan Z, Topaloglu M, Taskiran O . Medical Research Council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome. Crit Care. 2020; 24(1):562. PMC: 7499929. DOI: 10.1186/s13054-020-03282-x. View

16.

Latronico N, Rasulo F, Eikermann M, Piva S . Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes. Crit Care. 2023; 27(1):439. PMC: 10644573. DOI: 10.1186/s13054-023-04676-3. View

17.

Scherbakov N, Knops M, Ebner N, Valentova M, Sandek A, Grittner U . Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation. J Cachexia Sarcopenia Muscle. 2016; 7(1):60-7. PMC: 4799857. DOI: 10.1002/jcsm.12068. View

18.

Kanova M, Kohout P . Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia. Int J Mol Sci. 2022; 23(15). PMC: 9368893. DOI: 10.3390/ijms23158396. View

19.

Reid M, Lannergren J, Westerblad H . Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002; 166(4):479-84. DOI: 10.1164/rccm.2202005. View

20.

Kowalewska P, Kowalewski J, Milkovich S, Sove R, Wang L, Whitehead S . Spectroscopy detects skeletal muscle microvascular dysfunction during onset of sepsis in a rat fecal peritonitis model. Sci Rep. 2022; 12(1):6339. PMC: 9012880. DOI: 10.1038/s41598-022-10208-w. View